Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Inventiva has announced its cash position and revenue for the first nine months of 2025, according to a company statement.
Inventiva, a biopharmaceutical company, saw its shares close down 4.02% on Friday, November 21, at 3.465 euros, erasing some of the week's gains. This…
Inventiva's stock ended the Thursday, November 20 session at 3.61 euros, up 4.34% from the previous close, following the completion of its capital inc…
The biopharmaceutical company Inventiva has announced that the bookrunners have exercised their option to subscribe for additional shares as part of i…
Biopharmaceutical company Inventiva announced on Monday the full exercise of the over-allotment option granted to banks as part of its public offering…
The biopharmaceutical company Inventiva has announced its intention to raise approximately $125 million through a public offering of American Deposita…
Inventiva has announced a temporary suspension of its stock trading on Euronext Paris due to a public offering in the United States.
Inventiva has announced the availability of documents for its upcoming mixed general meeting scheduled for November 27, 2025.
Inventiva stands out from the general apathy of the French market. The stock is up 5.56% mid-day while the CAC 40 is down 0.51%. This divergence refle…
Inventiva recorded another significant trading session increase this Wednesday at market close, surpassing the 3.76 euros mark. This rise comes amid a…
